Discover the latest news, blogs, articles and interviews from GeneFirst.
GeneFirst announces the publication of new health economic evidence...
Unleashing the Power of Genome Sequencing in Drug Discovery: Innovative Approaches to 'Drug the Undruggable'
GeneFirst is attending the Med-Tech Innovation Expo 2023
FFPE: The Foundation of Clinical Genomics Research
Thought piece: Cancer in the UK: Overview 2023
World Cancer Day: The Importance of Raising Awareness about Blood Cancer
Get Acquainted with Liquid Biopsies
Eurogin 2023 - That's a wrap!
GeneFirst is attending Eurogin 2023
Medica 2022, Dusseldorf
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection
GeneFirst will be attending Medica 2021 in Düsseldorf
NEW publication on the utility of GeneFirst’s ATOM-Seq™ NGS library preparation technology for use with cfDNA and cfRNA
GeneFirst develops Real-Time PCR tests for detection of the new coronavirus 2019-nCoV
GeneFirst wins €2.9m Horizon 2020 grant to deliver predictive diagnostic panel for HPV infections evolving into cervical cancer
GeneFirst wins Innovate UK’s Shanghai-UK competition for the development of non-invasive test for cancer
Harnessing the Potential of Genomics: Empowering Cancer Care through Inherited Mutations and Equitable Access to Genomic Testing
Advancing Cervical Cancer Prevention: Genefirst's Breakthrough in Cervical Screening
Screening innovations strengthen fight against cervical cancer
Reflecting on National Women's History Month
Reflecting on Myeloma Awareness Month
Revolutionising Cancer Diagnostics: The Many Applications of Liquid Biopsies
Four ways to spread awareness during Ovarian Cancer Awareness Month
We're in Bilbao, Spain for Eurogin 2023
The story of HPV
GeneFirst at NextGen Omics 2022
GeneFirst COVID-19 kits and new Variant of Concern, Omicron
Innovative UK SME GeneFirst and University of Leeds win £1.4M NIHR grant to clinically validate the use of a novel NGS based technology in bowel cancer screening
GeneFirst launches CE-IVD COVID-19 test kit.
NEW publication on the analytical performance of Papilloplex HR-HPV
GeneFirst wins second major Innovate UK competitive grant to improve cancer treatment using its ATOM-seq™ NGS technology
